Arterra Pet Science: Funding Rounds, Investors & CEO

About Arterra Pet Science

Arterra Pet makes wellness supplements and dental-care products for adult and senior dogs. Its catalog includes dental chews, remineralizing toothpaste and multivitamin chews. The dental products use nano-hydroxyapatite, the mineral found in natural tooth enamel. In 2024, its adult and senior powders combined 63 ingredients in one daily scoop. Those formulas were designed to support six wellness areas, including joints, digestion and immune function.

Arterra added Amazon distribution in July 2024 and now ships throughout the United States, including Hawaii and Alaska. Jonathan Willbanks was founder and chief executive officer when Amazon distribution was announced. Jason Charms signed as CEO in November 2026. The business is based in Leander, Texas.

Funding Rounds (SEC Form D)

First sale	Filed with SEC	Amount sold	Investors	Avg. check	Terms	Filing
Oct 29, 2026	Nov 13, 2026	$1,578,575of $1.6M target	11	$143K	EquityRule 506(b)	Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Why Investors Backed Arterra Pet Science

Arterra argues that many condition-specific dog supplements follow a low-cost, low-benefit model. Backers are betting on its focus on efficacy, ingredient sources and ingredient forms rather than label appeal. [3]

Origin and Team

Jonathan Willbanks founded Arterra and was its chief executive officer when it announced Amazon distribution. [3]

Product and Technology

Arterra describes an “entourage effect” in which compounds work together. It uses mushroom fruiting bodies instead of mycelium. Arterra links ingredient form to absorption. [3]